Eric Schmidt FCA
Stock Analyst at Cantor Fitzgerald
(4.86)
# 357
Out of 4,673 analysts
44
Total ratings
53.5%
Success rate
84.3%
Average return
Main Sectors:
Stocks Rated by Eric Schmidt FCA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| POWL Powell Industries | Reiterated: Hold | $235 | $197.67 | +18.89% | 1 | Aug 14, 2026 | |
| DYN Dyne Therapeutics | Initiated Coverage: Buy | n/a | $26.10 | - | 1 | Jul 23, 2026 | |
| BIIB Biogen | Initiated Coverage: Buy | $206 | $216.78 | -4.97% | 4 | Jun 22, 2026 | |
| ODTX Odyssey Therapeutics | Initiated Coverage: Buy | n/a | $26.39 | - | 1 | Jun 2, 2026 | |
| LONA LeonaBio | Reiterated: Buy | n/a | $7.69 | - | 2 | Apr 7, 2026 | |
| GENB Generate Biomedicines | Initiated Coverage: Buy | n/a | $16.12 | - | 1 | Mar 24, 2026 | |
| SRRK Scholar Rock Holding | Maintained: Buy | n/a | $56.50 | - | 2 | Mar 19, 2026 | |
| LEGN Legend Biotech | Maintained: Buy | $75 → $74 | $21.82 | +239.14% | 4 | Dec 17, 2025 | |
| VSTM Verastem | Initiated Coverage: Buy | n/a | $6.89 | - | 1 | Oct 16, 2025 | |
| ALMS Alumis | Reiterated: Buy | n/a | $24.17 | n/a | 3 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $81.50 | n/a | 1 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $9.08 | n/a | 1 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $13.16 | n/a | 8 | Jul 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $44.37 | n/a | 1 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $9.45 | n/a | 2 | Jun 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $8.93 | n/a | 3 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $33.09 | n/a | 3 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $17.15 | n/a | 1 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $0.9966 | n/a | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $127.81 | n/a | 1 | Apr 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $23.88 | n/a | 1 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $36.88 | n/a | 1 | Nov 2, 2023 |
Powell Industries
Aug 14, 2026
Reiterated: Hold
Price Target: $235
Current: $197.67
Upside: +18.89%
Dyne Therapeutics
Jul 23, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $26.10
Upside: -
Biogen
Jun 22, 2026
Initiated Coverage: Buy
Price Target: $206
Current: $216.78
Upside: -4.97%
Odyssey Therapeutics
Jun 2, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $26.39
Upside: -
LeonaBio
Apr 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $7.69
Upside: -
Generate Biomedicines
Mar 24, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $16.12
Upside: -
Scholar Rock Holding
Mar 19, 2026
Maintained: Buy
Price Target: n/a
Current: $56.50
Upside: -
Legend Biotech
Dec 17, 2025
Maintained: Buy
Price Target: $75 → $74
Current: $21.82
Upside: +239.14%
Verastem
Oct 16, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $6.89
Upside: -
Alumis
Aug 14, 2025
Reiterated: Buy
Price Target: n/a
Current: $24.17
Upside: n/a
Aug 13, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $81.50
Upside: n/a
Aug 13, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $9.08
Upside: n/a
Jul 28, 2025
Reiterated: Buy
Price Target: n/a
Current: $13.16
Upside: n/a
Jul 25, 2025
Reiterated: Buy
Price Target: n/a
Current: $44.37
Upside: n/a
Jun 20, 2025
Reiterated: Hold
Price Target: n/a
Current: $9.45
Upside: n/a
Jun 2, 2025
Reiterated: Buy
Price Target: n/a
Current: $8.93
Upside: n/a
May 13, 2025
Reiterated: Buy
Price Target: n/a
Current: $33.09
Upside: n/a
Mar 21, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $17.15
Upside: n/a
May 30, 2024
Initiated Coverage: Buy
Price Target: n/a
Current: $0.9966
Upside: n/a
Apr 23, 2024
Initiated Coverage: Hold
Price Target: n/a
Current: $127.81
Upside: n/a
Apr 4, 2024
Initiated Coverage: Buy
Price Target: n/a
Current: $23.88
Upside: n/a
Nov 2, 2023
Initiated Coverage: Buy
Price Target: n/a
Current: $36.88
Upside: n/a